These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19246727)

  • 1. The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation.
    McBride BF
    J Clin Pharmacol; 2009 Mar; 49(3):258-67. PubMed ID: 19246727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vernakalant hydrochloride for the treatment of atrial fibrillation.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation.
    Tanaka H; Hashimoto N
    Cardiovasc Drug Rev; 2007; 25(4):342-56. PubMed ID: 18078434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Downstream approaches to atrial fibrillation: the new rhythm control drugs and promising targets].
    Yamashita T
    Nihon Yakurigaku Zasshi; 2010 Feb; 135(2):62-5. PubMed ID: 20154412
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifibrillatory agents and potassium channels in the atria: pore block versus channel trafficking.
    McEwen DP; Martens JR
    Mol Interv; 2009 Apr; 9(2):79-86. PubMed ID: 19401540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
    Trotter BW; Nanda KK; Kett NR; Regan CP; Lynch JJ; Stump GL; Kiss L; Wang J; Spencer RH; Kane SA; White RB; Zhang R; Anderson KD; Liverton NJ; McIntyre CJ; Beshore DC; Hartman GD; Dinsmore CJ
    J Med Chem; 2006 Nov; 49(24):6954-7. PubMed ID: 17125248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.
    Li GR; Wang HB; Qin GW; Jin MW; Tang Q; Sun HY; Du XL; Deng XL; Zhang XH; Chen JB; Chen L; Xu XH; Cheng LC; Chiu SW; Tse HF; Vanhoutte PM; Lau CP
    Circulation; 2008 May; 117(19):2449-57. PubMed ID: 18458165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia.
    Blass BE; Fensome A; Trybulski E; Magolda R; Gardell SJ; Liu K; Samuel M; Feingold I; Huselton C; Jackson CM; Djandjighian L; Ho D; Hennan J; Janusz JM
    J Med Chem; 2009 Nov; 52(21):6531-4. PubMed ID: 19888755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.
    Baczko I; Liknes D; Yang W; Hamming KC; Searle G; Jaeger K; Husti Z; Juhasz V; Klausz G; Pap R; Saghy L; Varro A; Dolinsky V; Wang S; Rauniyar V; Hall D; Dyck JR; Light PE
    Br J Pharmacol; 2014 Jan; 171(1):92-106. PubMed ID: 24102184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pharmacological targets and treatments for atrial fibrillation.
    Carlsson L; Duker G; Jacobson I
    Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.
    Walfridsson H; Anfinsen OG; Berggren A; Frison L; Jensen S; Linhardt G; Nordkam AC; Sundqvist M; Carlsson L
    Europace; 2015 Mar; 17(3):473-82. PubMed ID: 25082948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias.
    Jackson CM; Blass B; Coburn K; Djandjighian L; Fadayel G; Fluxe AJ; Hodson SJ; Janusz JM; Murawsky M; Ridgeway JM; White RE; Wu S
    Bioorg Med Chem Lett; 2007 Jan; 17(1):282-4. PubMed ID: 17095219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inward rectifier potassium currents as a target for atrial fibrillation therapy.
    Ehrlich JR
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):129-35. PubMed ID: 18670367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value.
    Ford JW; Milnes JT
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):105-20. PubMed ID: 18670369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.